(Q44414211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

main subject

adenosquamous carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Catherine Shu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Haiying Cheng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Antai Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Mahesh M Mansukhani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Balazs Halmos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Alain C Borczuk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

21 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

239-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996376%20AND%20SRC:MED&resulttype=core&format=json

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Histological typing of lung and pleural tumours: third edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Thymidylate synthase (TS) gene expression in primary lung cancer patients: a large-scale study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

KRAS mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

Adenosquamous carcinoma of the lung. Surgical results compared with squamous cell and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

7 January 2021

Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

7 January 2021

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

7 January 2021

Clinicopathologic characteristics of adenosquamous carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.158

7 January 2021